LSV Asset Management Has $61.93 Million Stock Position in Sabra Healthcare REIT, Inc. $SBRA

Posted by George Bondi on May 24th, 2026

LSV Asset Management reduced its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) by 9.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,270,015 shares of the real estate investment trust’s stock after selling 348,900 shares during the quarter. LSV Asset Management’s holdings in Sabra Healthcare REIT were worth $61,934,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in SBRA. Principal Financial Group Inc. grew its holdings in shares of Sabra Healthcare REIT by 21.6% during the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after buying an additional 4,431,897 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Sabra Healthcare REIT by 1,019.8% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock valued at $56,922,000 after buying an additional 2,736,993 shares during the last quarter. Balyasny Asset Management L.P. acquired a new position in shares of Sabra Healthcare REIT during the second quarter valued at about $49,955,000. Qube Research & Technologies Ltd grew its holdings in shares of Sabra Healthcare REIT by 856.5% during the second quarter. Qube Research & Technologies Ltd now owns 1,398,965 shares of the real estate investment trust’s stock valued at $25,797,000 after buying an additional 1,252,708 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in shares of Sabra Healthcare REIT by 33.7% during the third quarter. JPMorgan Chase & Co. now owns 3,589,253 shares of the real estate investment trust’s stock valued at $66,904,000 after buying an additional 903,841 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SBRA has been the subject of a number of analyst reports. Truist Financial lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Monday, May 18th. UBS Group boosted their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Wednesday, May 13th. Weiss Ratings cut shares of Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a report on Friday, May 1st. Finally, Scotiabank boosted their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “sector perform” rating in a report on Thursday. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $22.30.

Get Our Latest Research Report on Sabra Healthcare REIT

Sabra Healthcare REIT Stock Up 0.0%

Sabra Healthcare REIT stock opened at $20.72 on Friday. Sabra Healthcare REIT, Inc. has a fifty-two week low of $17.08 and a fifty-two week high of $21.28. The stock has a market cap of $5.23 billion, a PE ratio of 32.89, a price-to-earnings-growth ratio of 1.66 and a beta of 0.67. The firm’s 50-day simple moving average is $20.32 and its 200 day simple moving average is $19.63. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business had revenue of $221.75 million for the quarter, compared to analysts’ expectations of $209.20 million. During the same period in the previous year, the company earned $0.37 earnings per share. The firm’s revenue for the quarter was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts predict that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Shareholders of record on Friday, May 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, May 15th. This represents a $1.20 annualized dividend and a yield of 5.8%. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

About Sabra Healthcare REIT

(Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.